Results 221 to 230 of about 5,153,703 (360)
Impact of COVID-19 restrictions on thyroid cancer diagnoses in a comprehensive cancer center (2017-2023). [PDF]
Mann H +10 more
europepmc +1 more source
Abstract The integration of modern systemic therapies with radiotherapy (RT) represents a promising strategy in breast cancer management, enhancing both locoregional control and systemic disease outcomes. This expert consensus from the Institut Curie Breast Radiotherapy Group focuses exclusively on modern systemic agents, synthesizing current evidence ...
Cezara Cheptea +5 more
wiley +1 more source
Outcomes and risk factors of hemorrhage in patients with resected brain metastases
What's New? Brain metastases may present with hemorrhage, yet risk factors and clinical outcomes remain unclear. Based on a cohort of 880 patients with resected brain metastases, this study identified tumor volume and primary tumor histology (melanoma and non‐small cell lung cancer) as key predictors of hemorrhage.
Melisa S. Guelen +17 more
wiley +1 more source
Integrating TERT promoter mutations into risk stratification of papillary thyroid cancer. [PDF]
Yoo JH +11 more
europepmc +1 more source
What's New? Terrestrial trunked radio (TETRA) is the standard digital communication system used by police and other emergency services in Great Britain. During active use, TETRA emits radiofrequency electromagnetic fields, which are potentially carcinogenic in humans.
Chiara Di Gravio +2 more
wiley +1 more source
BRAF V600E in thyroid cancer: navigating prognostic uncertainty and therapeutic opportunity. [PDF]
Riesco-Eizaguirre G.
europepmc +1 more source
What's New? Anti‐angiogenic drugs have shown promising efficacy as a second‐line treatment for advanced gastric cancer. However, it remains unclear how alterations in the tumor microenvironment following first‐line immunotherapy may impact tumor angiogenesis and influence subsequent therapeutic outcomes. This single‐arm study prospectively explored the
Xiaoting Ma +11 more
wiley +1 more source

